Skip to Content

Mechanisms of Sensitivity and Resistance of Multiple Myeloma to NK Cells Can Potentially Lead to New Treatments

Sara Gandolfi, from the Hematology Research Unit in Helsinki, presented research at the EHA 2024 conference on how natural killer (NK) cells interact with hematologic cancers like multiple myeloma. Her studies aim to uncover mechanisms behind tumor cell resistance to NK cells, potentially leading to new treatments targeting these pathways.

Sara Gandolfi

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top